Diamyd Medical AB Expands Its Scientific Advisory Board
6/13/2013 8:54:54 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Diamyd Medical recently acquired exclusive rights relating to the therapeutic
use of GABA for the treatment of diabetes and other inflammation-related
conditions. The Company is now expanding its Scientific and Medical Advisory
Board with three internationally leading experts on GABA and diabetes: Dr.
Bryndis Birnir, Dr. Brooke Ligon, and Dr. Qinghua Wang.
Help employers find you! Check out all the jobs and post your resume.